2004•Pathology - Research and PracticeRequires access

Correlation of the c-kit mutational status of gastrointestinal stromal tumors with the clinical response to the tyrosine kinase inhibitor imatinib

K. Amande M. Pauls, Peter Hohenberger, Sabine Merkelbach‐Bruse, Torsten Pietsch, Thomas Heinicke, Roland Büttner, Eva Wardelmann

Open publisher page 1 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Imatinib, Tyrosine-kinase inhibitor, GiST, Stromal cell, Tyrosine kinase, Cancer research, Correlation, Medicine

Back to paper search Browse research topics Original source

Correlation of the c-kit mutational status of gastrointestinal stromal tumors with the clinical response to the tyrosine kinase inhibitor imatinib — Research Paper | ScholarLens